-
Safety and tolerability of bismuthyl ecabet suspension, a novel anti-ulcer agent, following single and multiple oral dose administration in healthy Chinese subjects.
Clinical drug investigation 20120401
-
Effect of ecabet sodium treatment on urea breath test and stool antigen tests in volunteers with Helicobacter pylori infection.
Journal of gastroenterology and hepatology 20120401
-
Triple therapy with ecabet sodium, amoxicillin and lansoprazole for 2 weeks as the rescue regimen for H. pylori infection.
Internal medicine (Tokyo, Japan) 20110101
-
Ecabet sodium: a potential new agent in the management of distal colitis.
Journal of gastroenterology and hepatology 20100701
-
Ecabet sodium promotes the healing of trinitrobenzene-sulfonic-acid-induced ulceration by enhanced restitution of intestinal epithelial cells.
Journal of gastroenterology and hepatology 20100701
-
Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study).
Journal of clinical pharmacy and therapeutics 20100601
-
Characteristic pathological findings and effects of ecabet sodium in rat reflux esophagitis.
World journal of gastroenterology 20090728
-
Identification of the metabolites of ecabet bismuth in rat bile by liquid chromatography-electrospray ionization-tandem mass spectrometry.
European journal of mass spectrometry (Chichester, England) 20090101
-
Ecabet sodium induces neuronal nitric oxide synthase-derived nitric oxide synthesis and gastric adaptive relaxation in the human stomach.
Journal of gastroenterology 20090101
-
Re-epithelialization of squamous epithelium for a radiation-induced rectal ulcer while giving an ecabet sodium enema.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 20090101
-
Effects of ecabet sodium on acute mixed reflux esophagitis in rats.
Scandinavian journal of gastroenterology 20090101
-
Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: prospective randomized study.
Hepato-gastroenterology 20090101
-
Determination of ecabet in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080301
-
H pylori eradication: a randomized prospective study of triple therapy with or without ecabet sodium.
World journal of gastroenterology 20080214
-
High affinity of ecabet sodium for inflamed colonic mucosa in ulcerative colitis.
Digestive diseases and sciences 20070601
-
Drug evaluation: TA-2711E in the treatment of active distal ulcerative colitis.
Current opinion in investigational drugs (London, England : 2000) 20070501
-
Ecabet sodium prevents esophageal lesions induced by the reflux of gastric juice in rats.
Inflammopharmacology 20070401
-
Efficacy of ecabet sodium enema on steroid resistant or steroid dependent ulcerative colitis.
Gut 20061001
-
Efficacy and safety of ecabet sodium on functional dyspepsia: a prospective, double-blinded, randomized, multi-center controlled trial.
World journal of gastroenterology 20060507
-
Comparison of the effects of cytoprotective drugs on human plasma adrenocorticotropic hormone and cortisol levels with continual stress exposure.
Biological & pharmaceutical bulletin 20051101
-
Ecabet sodium raises plasma levels of calcitonin generelated peptide and substance P in healthy humans.
The Journal of pharmacy and pharmacology 20050601
-
[Enema therapy for ulcerative colitis patients].
Nihon rinsho. Japanese journal of clinical medicine 20050501
-
Therapeutic effects of ecabet sodium, an antiulcer drug, on dextran sodium sulfate-induced ulcerative colitis in rats.
Digestive diseases and sciences 20050501
-
Ecabet sodium prevents the delay of wound repair in intestinal epithelial cells induced by hydrogen peroxide.
Journal of gastroenterology 20050501
-
Ecabet sodium inhibits Helicobacter pylori lipopolysaccharide-induced activation of NADPH oxidase 1 or apoptosis of guinea pig gastric mucosal cells.
American journal of physiology. Gastrointestinal and liver physiology 20050201
-
Combination therapy of ecabet sodium and cimetidine compared with cimetidine alone for gastric ulcer: prospective randomized multicenter study.
Journal of gastroenterology and hepatology 20030901
-
Inhibition of peptic ulcer relapse by ranitidine and ecabet independently of eradication of Helicobacter pylori: a prospective, controlled study versus ranitidine.
Hepato-gastroenterology 20030101
-
Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20030101
-
Inhibition of Helicobacter pylori-induced nuclear factor-kappa B activation and interleukin-8 gene expression by ecabet sodium in gastric epithelial cells.
Helicobacter 20030101
-
Ecabet sodium attenuates reactive oxygen species produced by neutrophils after priming with bacterial lipopolysaccharides.
Luminescence : the journal of biological and chemical luminescence 20030101
-
[QOL and the older people with peptic ulcer].
Nihon rinsho. Japanese journal of clinical medicine 20020801
-
Chemistry and mechanism of urease inhibition.
Current medicinal chemistry 20020701
-
[Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Ecabet sodium].
Nihon rinsho. Japanese journal of clinical medicine 20020201
-
[Effect of antiulcer agents on the urea breath test--Comparison between rebamipide and ecabet sodium].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20020101
-
Single administration of ecabet sodium diminishes the level of delta-13CO2 in urea breath test.
Journal of gastroenterology 20020101
-
Effects of ecabet sodium, an antiulcer drug, on gastric adaptive relaxation in isolated guinea-pig stomachs.
Drugs under experimental and clinical research 20020101
-
Effects of anti-ulcer agents on ethanol-induced gastric mucosal lesions in D-galactosamine-induced hepatitis rats.
Arzneimittel-Forschung 20020101
-
Effects of the anti-ulcer agents ecabet sodium, cimetidine and sucralfate on acetylsalicylic acid-induced gastric mucosal damage deteriorated by renal failure in rats.
Arzneimittel-Forschung 20020101
-
Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen.
Alimentary pharmacology & therapeutics 20010801
-
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.
Scandinavian journal of gastroenterology 20010701
-
Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
Clinical science (London, England : 1979) 20010401
-
Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study.
The American journal of gastroenterology 20010301
-
Ecabet sodium inhibits the ability of Helicobacter pylori to induce neutrophil production of reactive oxygen species and interleukin-8.
Journal of gastroenterology 20010301